Stock WGS GENEDX HOLDINGS CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Company GeneDx Holdings Corp.

Equities

WGS

US81663L2007

Healthcare Facilities & Services

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
11.08 USD -0.81% Intraday chart for GeneDx Holdings Corp. +14.94% +302.91%
Apr. 23 Genedx Announces Partnership with Komodo Health to Expand Access to World?S Largest Rare Disease Dataset CI
Apr. 15 Goldman Sachs Adjusts GeneDx Holdings Price Target to $11 From $6, Maintains Neutral Rating MT

Business Summary

GeneDx Holdings Corp. is a genomics company. The Company is focused on delivering personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The Company's segments are GeneDx inclusive of Legacy GeneDx and Legacy Sema4. The GeneDx segment primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. GeneDx utilizes an integrated portfolio of laboratory processes, software tools, and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. GeneDx provides a variety of genetic diagnostic tests, screening solutions, and information. The Legacy Sema4 diagnostics segment provides reproductive and women's health and somatic oncology diagnostic testing and screening products.

Number of employees: 1,000

Sales per Business

USD in Million2022Weight2023Weight Delta
GeneDx
96.0 %
122 52.1 % 194 96.0 % +59.02%
Legacy Sema4
4.0 %
112 47.9 % 8 4.0 % -92.72%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
235 100.0 % 203 100.0 % -13.69%

Managers

Managers TitleAgeSince
Katherine Stueland CEO
 Chief Executive Officer 48 22-04-28
Kevin Feeley DFI
 Director of Finance/CFO 43 -
Paul Kruszka CTO
 Chief Tech/Sci/R&D Officer - -
Murali Mani CMP
 Compliance Officer - 19-12-31
Eli Casdin BRD
 Director/Board Member 51 20-06-30
Melanie Duquette PRN
 Corporate Officer/Principal - 23-09-10
Devin Schaffer LAW
 General Counsel - 23-04-23
Kareem Saad PRN
 Corporate Officer/Principal 45 21-07-21

Members of the board

Members of the board TitleAgeSince
Joshua Ruch BRD
 Director/Board Member 74 21-07-21
Richard Pfenniger BRD
 Director/Board Member 68 22-04-30
Keith Meister BRD
 Director/Board Member 51 20-12-31
Eli Casdin BRD
 Director/Board Member 51 20-06-30
Katherine Stueland CEO
 Chief Executive Officer 48 22-04-28
Jason Ryan CHM
 Chairman 49 21-07-21
Emily Leproust BRD
 Director/Board Member 50 20-08-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 26,053,551 18,227,102 ( 69.96 %) 0 69.96 %

Shareholders

NameEquities%Valuation
The Mount Sinai Hospital
14.33 %
3,732,630 14.33 % 34 M $
OPKO HEALTH, INC.
13.66 %
3,558,601 13.66 % 32 M $
Casdin Capital LLC
11.88 %
3,095,511 11.88 % 28 M $
Corvex Management LP
9.495 %
2,473,781 9.495 % 23 M $
Goldman Sachs & Co. LLC
6.474 %
1,686,831 6.474 % 15 M $
Blackstone Corporate Private Equity
3.205 %
835,062 3.205 % 8 M $
Morgan Stanley Capital Services LLC
3.010 %
784,128 3.010 % 7 M $
Vanguard Global Advisers LLC
2.606 %
678,934 2.606 % 6 M $
Deerfield Management Co. LP (Private Equity)
2.468 %
643,110 2.468 % 6 M $
Gagnon Securities LLC
1.341 %
349,278 1.341 % 3 M $
NameEquities%Valuation
LMR Partners LLP
-
1,532,805 - 84 304 $
Cowen & Co. LLC
-
1,138,088 - 62 595 $
Ionic Capital Management LLC
-
591,313 - 32 522 $
D.E. Shaw & Co., Inc.
-
467,197 - 25 696 $
Weiss Multi-Strategy Advisers LLC
-
304,201 - 16 731 $
UBS Securities LLC
-
124,865 - 6 868 $
Q Global Advisors LLC
-
115,474 - 6 351 $
MSD Partners LP
-
100,000 - 5 500 $
Sona Asset Management (US) LLC
-
51,582 - 2 837 $
TD Asset Management, Inc. (13F Subfiler)
-
34,884 - 1 919 $

Company contact information

GeneDx Holdings Corp.

North Tower 333 Ludlow Street

06902, Stamford

+

http://www.genedx.com
address GeneDx Holdings Corp.(WGS)

Sector

Healthcare
Healthcare Services
Healthcare Providers & Services
Healthcare Facilities & Services
Medical & Diagnostic Laboratories

Sales per Business

Ratings for GeneDx Holdings Corp.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
11.08 USD
Average target price
11.38 USD
Spread / Average Target
+2.66%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

1st Jan change Capi.
GENEDX HOLDINGS CORP. Stock GeneDx Holdings Corp.
+302.91% 289M
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-17.89% 8.25B
RADNET, INC. Stock RadNet, Inc.
+39.20% 3.58B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-39.11% 2.46B
SYNLAB AG Stock SYNLAB AG
-8.06% 2.46B
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
-7.35% 2.38B
NEOGENOMICS, INC. Stock NeoGenomics, Inc.
-12.61% 1.81B
FLEURY S.A. Stock Fleury S.A.
-19.01% 1.55B
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-40.66% 1.21B
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+7.56% 1.11B
Medical & Diagnostic Laboratories
  1. Stock Market
  2. Equities
  3. WGS Stock
  4. Company GeneDx Holdings Corp.